ACEP and nearly 50 physician groups and other organizations are sharing deep concerns about the recently announced 15% cap on indirect cost recovery for National Institutes of Health (NIH) grants. ACEP urges NIH to rescind this directive and work collaboratively to develop a solution that balances transparency, efficiency, and sustainability.
The letter details the importance of using federal research dollars effectively and states:
“The collateral damage of this policy, if implemented, will be profound and generational, reshaping the future of scientific progress in ways that cannot be easily undone. Beyond its immediate financial strain, the policy introduces significant procedural and structural issues that undermine the integrity of federal research funding.”
Outlined concerns span research institution funding, career development and talent recruitment, efforts to sustain globally competitive United States-led research innovation, and more. Read the letter.
Related:
ACEP Advocacy: New Challenges, New Opportunities to Speak Out
Summary of President Trump’s Executive Orders
ACEP resource: Navigating Immigration Enforcement in the Emergency Department
ACEP to Trump Administration: We Must Ensure Robust Health Care Infrastructure
